Homologies between SARS-CoV-2 and allergen proteins may direct T cell-mediated heterologous immune responses
Abstract The outbreak of the new severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a public health emergency. Asthma does not represent a risk factor for COVID-19 in several published cohorts. We hypothesized that the SARS-CoV-2 proteome contains T cell epitopes, which are potentially...
Guardado en:
Autores principales: | Kathrin Balz, Abhinav Kaushik, Meng Chen, Franz Cemic, Vanessa Heger, Harald Renz, Kari Nadeau, Chrysanthi Skevaki |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d7ea8bc1a9ad40099bef607fbcee3efe |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1.
por: Bimmi Shrestha, et al.
Publicado: (2010) -
Homology between SARS CoV-2 and human proteins
por: Vladimir Khavinson, et al.
Publicado: (2021) -
Intradermal vaccination of live attenuated influenza vaccine protects mice against homologous and heterologous influenza challenges
por: Andrew Chak-Yiu Lee, et al.
Publicado: (2021) -
Nanoparticle–allergen complexes for allergen immunotherapy
por: Di Felice G, et al.
Publicado: (2017) -
Editorial: Activation of Innate Immunity by Allergens and Allergenic Sources
por: Fatima Ferreira, et al.
Publicado: (2021)